Loomis, Sayles & Company
DRNA

Loomis, Sayles & Company’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Loomis, Sayles & Company’s Portfolio DRNA Stock Details DRNA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
2021
Q2 		$58.2M Sell
2021
Q1 		$40.7M Buy
2020
Q4 		$30.2M Buy
2020
Q3 		$19M Buy
2020
Q2 		$18.4M Buy